Panic Disorders Market Report 2026

Panic Disorders Market Overview

• Panic Disorders market size has reached to $11.15 billion in 2025 • Expected to grow to $15 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Telehealth's Transformative Impact On The Panic Disorders Market • Market Trend: Pharmaceutical Companies Focus On Extended-Release Capsules For Panic Disorder Treatment Advancements • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Panic Disorders Market?

Panic disorder is a specific type of anxiety illness characterized by unanticipated and recurrent attacks of high anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Panic disorder is generally treated with medication and psychotherapy. The main types of panic disorders are agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCS), bipolar disorder, post-traumatic stress disorder (PTSD), and major depressive disorder. Agoraphobia refers to the deliberate avoidance of locations or circumstances that potentially induce symptoms of panic and elicit sensations of confinement, helplessness, or social discomfort. The various treatments are medication, beta-blockers, serotonin and norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, anti-epilepsy, and others administered through oral, parenteral, and others. The end users are hospital pharmacies, retailer pharmacies, and online pharmacy stores.

What Is The Panic Disorders Market Growth Forecast?

The panic disorders market size is expected to see strong growth in the next few years. It will grow to $15 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing prevalence of anxiety and panic disorders, growth in telepsychiatry adoption, advancements in virtual reality and neurofeedback therapies, expansion of online pharmacy and hospital distribution channels, rising demand for personalized mental healthcare plans. Major trends in the forecast period include rising adoption of telepsychiatry and mobile mental health applications, integration of virtual reality therapy for anxiety disorders, increasing use of biofeedback and neurofeedback techniques, growth in personalized medication plans for panic disorders, expansion of mental healthcare facilities and hospital services.

Global Panic Disorders Market Segmentation

1) By Treatment Type: Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies 2) By Disorder Type: Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Mild Panic Disorder, Moderate Panic Disorder, Severe Panic Disorder, Panic Disorder With Comorbidities 3) By Age Group: Children And Adolescents, Adults, Elderly 4) By End User: Hospitals, Specialty Mental Health Clinics, Primary Care Clinics, Telehealth And Digital Platforms, Home Healthcare Services Subsegments: 1) By Pharmacotherapies: Antidepressants, Benzodiazepines, Beta-Blockers 2) By Psychotherapeutic Interventions: Cognitive Behavioral Therapy (CBT), Exposure Therapy, Psychodynamic Therapy, Group And Family Therapy 3) By Digital Or Tech-Enabled Therapies: Mental Health Apps, Telepsychiatry Or Teletherapy, Virtual CBT Programs

What Is The Driver Of The Panic Disorders Market?

The increasing utilization of telehealth is expected to propel the growth of the panic disorders market going forward. Telehealth uses electronic communication technologies, such as videoconferencing, phone calls, and secure messaging, to provide remote healthcare services and medical consultations. Telehealth facilitates psychotherapy and counseling services for individuals with panic disorders. Therapists can conduct individual therapy sessions, group therapy, or support groups via secure videoconferencing platforms. For instance, in April 2023, FAIR Health Inc., a US-based non-profit organization, showed a 7.3% national increase in telehealth usage, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing utilization of telehealth is driving the growth of the panic disorders industry.

Key Players In The Global Panic Disorders Market

Major companies operating in the panic disorders market are F. Hoffmann‑La Roche Ltd, Sanofi S.A, Bristol‑Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc, Sun Pharmaceutical Industries Ltd, H. Lundbeck A/S, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc, Sumitomo Pharma Co Ltd, LIFECARE NEURO PRODUCTS LTD, Merck & Co Inc, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co Ltd.

Global Panic Disorders Market Trends and Insights

Major companies operating in the panic disorder market are focusing on developing advanced medicines, such as extended-release capsules, to sustain their position in the market. Extended-release capsules are medications that release the active ingredient slowly over a while, typically 12 or 24 hours, to treat conditions requiring medication to be taken over a long period. For instance, in May 2023, Granules India Ltd., an India-based pharmaceutical company, received abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for venlafaxine hydrochloride extended-release capsules. It demonstrates bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed for the management of conditions including generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They work by increasing the levels of serotonin and norepinephrine in the brain, and the dosage is usually started at 75 mg per day and may be increased by the doctor as needed.

What Are Latest Mergers And Acquisitions In The Panic Disorders Market?

In February 2023, Vistagen Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, acquired Pherin Pharmaceuticals Inc. for an undisclosed amount. This acquisition enables Vistagen to develop and commercialize innovative treatments for individuals with depression and anxiety disorders. This deal is expected to significantly improve each drug candidate's potential future commercial profile. Pherin Pharmaceuticals Inc. is a US-based pharmaceutical company specializing in drug development for panic disorders.

Regional Outlook

North America was the largest region in the panic disorders market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Panic Disorders Market?

The panic disorder market consists of revenue earned by entities by providing services such as physical tests, cognitive behavioral therapy (CBT), and psychological evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic disorder market includes sales of tablets and injectables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Panic Disorders Market Report 2026?

The panic disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the panic disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.